Dietary Supplements Seized From Globe All Wellness Due to Violations
In Hollywood (Florida, not California), tainted dietary supplements were seized by members of the United States Marshals. The products were taken from a company called Globe All Wellness following inspections carried out last October and this month by the Food and Drug Administration. These inspections revealed that a variety of supplements were produced out of… read more
Santa Fe Springs Dietary Supplement and Drug Maker Shut Down
Violations of the Federal Food, Drug, and Cosmetic Act have prompted a judge to shut down a company based in Santa Fe Springs, California. Until Titan Medical Enterprises gets its manufacturing practices in line with the requirements of the aforementioned act, they will not be able to produce or distribute dietary supplements and drugs. Inspections… read more
Doctors Urged By FDA To Use Caution With All-Metal Hip Implants
Recently, the Food and Drug Administration issued new safety directives meant to be followed by healthcare professionals thinking about recommending a hip implant to a patient. The FDA’s new guidelines were released in order to ensure that all patients are made aware of the potentially heightened risks of submitting to a procedure involving a metal… read more
FDA Warns of Liver Damage Risk Possibly Posed By Samsca
The Food and Drug Administration is warning doctors and consumers alike of the potential liver damage that could result due to the consumption of the drug known as Samsca, or tolvaptan. During a three year clinical trial partially involving the use of placebos, three patients experienced liver enzyme abnormalities. Doctors stopped providing the persons with… read more
Flu Treatment Product Shortages Possible, But Very Limited
The Food and Drug Administration Commissioner is warning consumers of potential shortages of preventative flu shots and treatments like Tamiflu which aim to cut down on flu symptoms and aid recovery. However, such shortages have thus far been reported only at the local level, and the FDA is doing what it can to get Tamiflu… read more
Sylmar Facility Warned of Possible Safety Issues By FDA
A medical device company with a facility in the Sylmar area of Los Angeles has been warned by the Food and Drug Administration of potential issues that could compromise the safety of patients. The company must react accordingly or risk further action by the FDA. The St. Paul, Minnesota-based St. Jude Medical was the recipient… read more
Driving Simulator To Be Used to Evaluate Anti-Insomnia Drugs
Last week, the Food and Drug Administration recommended that people taking Ambien and other anti-insomnia drugs be given lower dosages so as to cut down on the chances that alertness could be compromised at the wheel. In a recent teleconference with reporters, a member of the FDA also revealed that driving simulators would increasingly be… read more
FDA Issues New Dosage Recommendations For Insomnia Drugs
A number of drug items that are meant to help users overcome insomnia have received new recommendations from the Food and Drug Administration. If you take such a drug, then you might want to read on. Zolpidem is the name of the drug that has prompted this additional FDA scrutiny. The drug can be found… read more
Review FDA’s Most Widely Read Consumer Alerts of 2012
The Food and Drug Administration regularly updates consumers with information pertaining to issues that could compromise safety. These can be things as wide-ranging as a safety issue presented in households across America or as specific as side effects entailed by a certain widely available ingredient in a series of health products. A new report provides… read more
Tainted Cantaloupe Producer Warned of Safety Issues By FDA
Followers of this blog and recall news in general may remember a series of recalls issued throughout the summer in conjunction with cantaloupes that may have been contaminated by Salmonella. From July through September, an estimated 261 people across the country reportedly became sick, exhibiting such symptoms as diarrhea, fever, and nausea. 94 of those… read more
FDA Warns oBand Centers About Website Marketing Materials
The Marina Del Rey-based oBand Centers has been the recipient of a warning letter from the Food and Drug Administration which was issued in regard to the way the company promoted the Lap-Band procedure through marketing materials. This isn’t the first time that the FDA has gotten involved in the promotion of the weight loss… read more
350 Healthcare Centers Warned of Unapproved Botox by the FDA
When one submits to a medical procedure, he or she relies on the fact that the equipment and the drugs being used are safe. Even one faulty or counterfeit component could be detrimental to a person’s wellbeing. The Food and Drug Administration attempts to keep tabs on such items, and that’s why you see warnings… read more